Growth Hormone Treatment of Short Stature: Status of the Quality of Life Rationale
Growth Hormone Treatment of Short Stature: Status of the Quality of Life Rationale
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
The unlimited availability of biosynthetic human growth hormone (rhGH) has contributed to the disassociation of the treatment of short stature from its causes. The rationale for treatment has traditionally rested upon the assumption that short stature, in the extreme, may constitute a physical disability, and otherwise represents a significant psyc...
Alternative Titles
Full title
Growth Hormone Treatment of Short Stature: Status of the Quality of Life Rationale
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1170750855
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1170750855
Other Identifiers
ISSN
1663-2818,0301-0163
E-ISSN
1663-2826
DOI
10.1159/000086593
